In the recent quarter, Pfizer Inc reported a drop in revenue as sales from its top-selling pneumonia vaccine decreased, according to The Wall Street Journal. Additionally, Pfizer’s sales outlook fell below Wall Street’s expectations. Global sales for the Prevnar vaccine dropped 24% to $1.4 billion in the latest quarter. Pfizer attributes the decrease to many eligible patients who are already vaccinated, the Journal reported. Additionally, the company cited the unfavorable timing of government purchases.
Aetna CEO Mark Bertolini remains hopeful in the next wave of health care reform, as well as the evolving health care policy landscape, according to The Milwaukee Wisconsin Journal Sentinel. Aetna lost $450 million last year selling individual policies, which includes those sold through the Affordable Care Act exchanges. Collectively, companies have lost billions of dollars, and most of the nonprofit companies that were started through the legislation have failed, the Sentinel reported. The uncertainty surrounding the future of Obamacare could result in a collapse of the market in 2018, according to health insurance experts. Initially, Bertolini confirmed this idea; however, Aetna is in talks with lawmakers, and Bertolini is optimistic that the replacement for Obamacare will be consumer-focused, high-quality, and affordable.